GERMIS
ActiveSummary
GERMIS has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €57,051 and a net result of €54,051. Equity remains stable across the filed financial years (±0.7% per year). Its solvency ranks better than 65% of 20,858 sector peers (NACE 62, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
22-06
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
24-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
22-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial
Equity above €100,000equity €124,070 ▲48.7%
A profit in every financial year since 2021 builds equity to €124,070.
28-06
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial
Highest result from 2021 to 2025net €64,512 ▲305%
Operating result €81,860, net result €64,512, both a record.
31-12
Financial
Liquidity more than doubledcurrent ratio 4.02
Current ratio from 1.67 to 4.02.
04-07
NBB filing
Annual accounts filed
financial year 2021 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.